Stock TTNP TITAN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Titan Pharmaceuticals, Inc.

Equities

TTNP

US8883147055

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
6.51 USD +2.36% Intraday chart for Titan Pharmaceuticals, Inc. +1.45% -21.09%
May. 15 Titan Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Titan Pharmaceuticals: Q1 Earnings Snapshot
AQ
Titan Pharmaceuticals : Non-Reliance on Previously Issued Financial Report - Form 8-K
PU
Titan Pharmaceuticals : Private Placement - Form 8-K
PU
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
AQ
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - December 28, 2023
AQ
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
AQ
Titan Pharmaceuticals: Q3 Earnings Snapshot
AQ
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
AQ
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
AQ
TITAN PHARMACEUTICALS : UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION - Form 8-K
PU
Titan Pharmaceuticals: Q2 Earnings Snapshot
AQ
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Shareholder Director Nominations, Financial Statements and Exhibits (form 8-K)
AQ
TITAN PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Vivakor Announces New Board of Directors
AQ
TITAN PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TITAN PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
TITAN PHARMACEUTICALS INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TTNP Stock
  4. News Titan Pharmaceuticals, Inc.
  5. Press Releases